
The Silent Threat of Heart Failure
Heart failure with preserved ejection fraction (H2FPEF) is a growing public health concern. Early identification and management are crucial for improving patient outcomes. However, traditional methods of assessing heart failure risk often lack precision and timeliness, hindering effective patient care.

The Devastating Impact of Heart Failure
Heart failure significantly impacts patients’ quality of life, leading to reduced independence, increased healthcare utilization, and higher mortality rates. Early detection and intervention are essential for preventing hospitalizations and improving patient outcomes.

Kribado: Your Partner in Heart Failure Management
Revolutionize Heart Failure Care with Instant Risk Assessment
Kribado is an innovative patient screening solution designed to accurately and efficiently assess heart failure risk. By leveraging the H2FPEF and advanced algorithms, Kribado empowers healthcare providers to optimize treatment plans and improve patient outcomes.
How Kribado Works
- Rapid Heart Failure Risk Assessment: Quickly assess patient heart failure risk.
- Data-Driven Insights: Gain valuable information to tailor treatment plans.
- Improved Patient Outcomes: Enhance patient well-being and overall heart health.
- Efficient Workflow Integration: Seamlessly integrate heart failure risk assessments into clinical practice.

Indian Technologies: Trusted by Pharmaceutical Leaders
Indigital Technologies LLP is a proven leader in pharmaceutical business growth. With a strong track record of delivering innovative solutions, we are committed to improving patient care and driving industry progress.